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Simply stated, organic synthesis may be viewed as the construc-
tion of target molecules by forming carbon–carbon bonds be-
tween appropriate structural fragments (synthons). In the
Baylis-Hillman reaction,1 first reported in the patent literature in
1972,2 multi-functional products (3) are obtained by reacting al-
dehydes (1) with activated alkenes (2) in the presence of a ter-
tiary amine catalyst, typically 1,4-diazabicyclo[2.2.2]octane
(DABCO) (Scheme 1). In an even earlier report, Morita et al.3 had
described the use of tertiary phosphine catalysts in similar trans-
formations and, consequently, in his review of the Baylis-Hill-
man reaction,4 Ciganek has suggested that the reaction should
be known as the ‘Morita-Baylis-Hillman’ reaction.
In our own research at Rhodes during the last fifteen years,
attention has been given to exploring both the mechanistic
basis and potential applications of this important reaction,
which has now achieved ‘text-book’ status!29 While generally
easily executed, Baylis-Hillman reactions
can be exceedingly slow — in some cases
requiring several weeks to afford reason-
able yields. Use of highly reactive pyridine-
carbaldehydes [e.g. (4)] as substrates re-
sults in significant rate acceleration,5 per-
mitting kinetic data to be collected in a
matter of hours. The resulting data pro-
vided the basis for the first reported ki-
netic-mechanistic study of the reaction6 —
a reaction in which formation of the zwit-
terionic species (7) (Scheme 2) is consid-
ered to be rate-determining. While collapse
of this intermediate could, in principle, fol-
low either E2 or E1CB pathways, the latter
appears to be supported by computational
results (manuscript in preparation).
Serendipity often plays a significant role
in scientific discovery and, in our own
research, served to introduce us to the
potential of the Baylis-Hillman reaction in
the construction of benzannulated hetero-
cyclic products. Attempted distillation of a
liquid Baylis-Hillman adduct of type (5)
afforded, unexpectedly, colourless crys-
tals, subsequent analysis of which indi-
cated the formation of the indolizine (6)
via thermal cyclization of the corresponding adduct (5) (Scheme
3).7 The generality of this approach to indolizines was demon-
strated,8 prompting us to explore the formation of other
benzannulated heterocycles, such as the chromenes (9), via simi-
lar cyclization of Baylis-Hillman adducts generated using
2-hydroxybenzaldehyde precursors (8) (Fig. 1). In an initial
attempt to exploit this approach,9 the novel, crystalline coumarin
derivative (10) (Scheme 4) was isolated in low yield. In subse-
quent studies,10,11 however, careful chromatographic separation
of the product mixtures afforded representative examples of no
less than eight classes of chromene and coumarin derivatives,
reflecting a cascade of competing and consecutive transforma-
tions (Fig. 2).
While these results clearly indicated the potential of the Baylis-
Hillman reaction in the construction of heterocyclic systems, it
was equally apparent that several questions needed to be
addressed if the method was to be synthetically useful. For
example: Could the regioselectivity of cyclization be controlled
to afford either chromenes (Path I; Fig. 2) or coumarins (Path II)
chemoselectively? Could the yields be improved? Could the
method be extended to include the preparation of nitrogen- and
sulphur-containing analogues? Could the putative intermediacy
of the Baylis-Hillman adducts (11) be confirmed?
The chemoselective synthesis of the chromene derivatives (14)
was successfully achieved using activated alkenes (12) (such as
vinyl ketones, sulphones or sulphonates) in which the activating
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group (R3) effectively inhibits cyclization via the
acyl substitution pathway (Path II; Scheme 5).12,13
Application of the Baylis-Hillman method to the
preparation of coumarin derivatives, however,
required inhibition of the conjugate addition path-
way (Path I), and several approaches to this prob-
lem were investigated. In the first (extending work
reported by Drewes et al.30), the nucleophilicity of
the phenolic oxygen was masked by O-benzylation
and the electrophilicity of the C–C double bond
by nucleophilic interception using an amine
(piperidine or benzylamine; Scheme 6).14 Debenzy-
lation of the protected intermediates (16) then
afforded the coumarin derivatives (17) and (18). In
an alternative but mechanistically similar
approach, the halogen acids, HI or HCl, were used
to effect the nucleophilic interception and deben-
zylation steps consecutively, in one pot, affording
the 3-halogenomethyl derivatives, (19) and (20),
respectively.15 In an even simpler approach
(Scheme 7), use of tert-butyl acrylate (21) as the
activated alkene permitted convenient,19 direct
access to the coumarin derivatives (20), (22) and
(23), without recourse to the use of any protecting
group strategies!
In principle, the direct formation of chromene
and coumarin derivatives from unprotected
2-hydroxybenzaldehydes could occur via the alter-
native pathways B and C, rather than the Baylis-
Hillman pathway A — as illustrated in Fig. 3. We
have, however, obtained and reported substantial
evidence for the intermediacy of Baylis-Hillman
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Fig. 1. Putative cyclization to chromene derivatives.
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adducts in these reactions.17
Extension of the general method to the preparation
of the sulphur-containing thiochromene analogues
(26) (Scheme 8) was facilitated by the spontaneous for-
mation of the disulphide (25) during oxidation of the
hydroxymethyl precursor (24) — a ‘self protection’
that effectively masks the nucleophilic thiol group.
Baylis-Hillman reactions of the disulphide dicarb-
aldehyde (24), using 1,6-diazabicyclo[4.4.0]undecane
(DBU) as the nucleophilic catalyst, afforded the
required products (26) directly and in good yield.
Somewhat surprisingly, but most conveniently, the
reaction conditions permit in situ reduction of the
disulfide moiety and consequent cyclization to the
required thiochromenes (26).18
2-Aminobenzaldehydes would seem, at first sight,
to be obvious Baylis-Hillman precursors for the
construction of quinolines (nitrogen-containing ana-
logues); they are, however, relatively inaccessible.
Moreover, the 2-amino group is expected to decrease
the electrophilicity of the aldehyde carbonyl group,
thus inhibiting reactivity under Baylis-Hillman condi-
tions. Consequently, 2-nitrobenzaldehydes were
explored as activated alternatives, subsequent reduc-
tion of the nitro group being expected to permit
cyclization of the resulting amine. As expected, reac-
tion of 2-nitrobenzaldehyde (27) with activated
alkenes [(28); Scheme 9] provided access to the corre-
sponding Baylis-Hil lman adducts (29) . The
regioselectivity of cyclization following reduction,
however, appears to depend on the nature of substi-
tuent ‘R’ in the activated alkene (28). Thus, acrylic
esters (R = OMe, OEt) appear to favour cyclization via
acyl substitution to give 2-quinolones [e.g. (30),
(32)–(34)], whereas, vinyl ketones [(28); e.g. R = Me]
favour cyclization via nucleophilic addition, in situ
dehydration affording quinoline N-oxides [e.g. (31)]
or quinolines directly.19
The quinoline nucleus is present in quinine and in
many synthetic anti-malarial agents, while indolizines, in addi-
tion to exhibiting various pharmacological effects, have found
use as dyes, photographic sensitizers and fabric brighteners.20,21
The oxygenated systems, coumarins and chromenes, are widely
distributed in nature, with many of them showing interesting
biological activity.22,23 In this general context, the development of
novel synthetic approaches to medicinally and technologically
useful compounds has obvious relevance.
We have also begun to explore specific Baylis-Hillman-derived
compounds as potential HIV-1 protease and integrase inhibi-
tors. Particular attention has been given to the preparation of
analogues of ritonavir (35), one of a number HIV-1 protease
inhibitors in clinical use.24,25 On binding to the enzyme active site,
such compounds block access by endogenous substrates, thus
inhibiting enzyme function critical for viral replication. Our
initial approach has been to prepare analogues (such as the
chromene-derived system (37) illustrated in Scheme 10), in
which Baylis-Hillman-derived heterocycles are attached to the
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Scheme 7
Fig. 3. Possible pathways to chromene and coumarin derivatives.
Scheme 8
amino termini of the hydroxyethylene dipeptide isostere
(36),26 present in ritonavir. A range of such analogues,
containing chromone or Baylis-Hillman-derived
chromene, thiochromene and coumarin systems, has
been prepared.27 Results from in silico enzyme-docking
studies and in vitro enzyme-inhibition assays indicate the
potential of some of these compounds to act as HIV-1
protease inhibitors.28 Current research in this area is
focused on developing structurally simpler (and, hence,
synthetically more accessible) Baylis-Hillman-derived
heterocyclic products as HIV-1 protease and integrase
inhibitors (V. Pakhade and D.M. Molefe, unpubl. obs.).
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